nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Metaraminol—Phenylpropanolamine—obesity	0.281	1	CrCrCtD
Tapentadol—SLC6A4—obesity	0.125	1	CbGaD
Tapentadol—SLC6A2—Diethylpropion—obesity	0.0468	0.117	CbGbCtD
Tapentadol—SLC6A4—Sibutramine—obesity	0.0424	0.106	CbGbCtD
Tapentadol—SLC6A2—Sibutramine—obesity	0.0354	0.0885	CbGbCtD
Tapentadol—SLC6A2—Phendimetrazine—obesity	0.0354	0.0885	CbGbCtD
Tapentadol—SLC6A4—Phentermine—obesity	0.0321	0.0802	CbGbCtD
Tapentadol—SLC6A2—Benzphetamine—obesity	0.0269	0.0671	CbGbCtD
Tapentadol—SLC6A2—Phentermine—obesity	0.0269	0.0671	CbGbCtD
Tapentadol—SLC6A4—Methamphetamine—obesity	0.0257	0.0641	CbGbCtD
Tapentadol—SLC6A2—Phenylpropanolamine—obesity	0.0256	0.064	CbGbCtD
Tapentadol—SLC6A2—Bupropion—obesity	0.0228	0.057	CbGbCtD
Tapentadol—SLC6A2—Methamphetamine—obesity	0.0215	0.0536	CbGbCtD
Tapentadol—HTR3A—area postrema—obesity	0.0107	0.375	CbGeAlD
Tapentadol—CYP2C9—Phentermine—obesity	0.00881	0.022	CbGbCtD
Tapentadol—CYP2D6—Phentermine—obesity	0.00805	0.0201	CbGbCtD
Tapentadol—CYP2C9—Bupropion—obesity	0.00749	0.0187	CbGbCtD
Tapentadol—CYP2D6—Bupropion—obesity	0.00685	0.0171	CbGbCtD
Tapentadol—CYP2C19—Cimetidine—obesity	0.00661	0.0165	CbGbCtD
Tapentadol—CYP2D6—Methamphetamine—obesity	0.00644	0.0161	CbGbCtD
Tapentadol—CYP2C9—Cimetidine—obesity	0.0055	0.0137	CbGbCtD
Tapentadol—CYP2D6—Cimetidine—obesity	0.00503	0.0125	CbGbCtD
Tapentadol—CYP2C19—Topiramate—obesity	0.00433	0.0108	CbGbCtD
Tapentadol—HTR3A—vagus nerve—obesity	0.00357	0.125	CbGeAlD
Tapentadol—SLC6A2—sympathetic nervous system—obesity	0.00247	0.0866	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—obesity	0.00166	0.0582	CbGeAlD
Tapentadol—SLC6A4—hindbrain—obesity	0.000795	0.0278	CbGeAlD
Tapentadol—Edrophonium—BCHE—obesity	0.00071	0.518	CrCbGaD
Tapentadol—UGT1A9—digestive system—obesity	0.000688	0.0241	CbGeAlD
Tapentadol—HTR3A—islet of Langerhans—obesity	0.000674	0.0236	CbGeAlD
Tapentadol—Rivastigmine—BCHE—obesity	0.00066	0.482	CrCbGaD
Tapentadol—HTR3A—respiratory system—obesity	0.000637	0.0223	CbGeAlD
Tapentadol—UGT1A9—endocrine gland—obesity	0.000569	0.0199	CbGeAlD
Tapentadol—UGT2B7—digestive system—obesity	0.000555	0.0194	CbGeAlD
Tapentadol—UGT1A9—liver—obesity	0.000513	0.018	CbGeAlD
Tapentadol—SLC6A4—respiratory system—obesity	0.000486	0.017	CbGeAlD
Tapentadol—UGT2B7—endocrine gland—obesity	0.000459	0.0161	CbGeAlD
Tapentadol—SLC6A2—respiratory system—obesity	0.000427	0.015	CbGeAlD
Tapentadol—UGT2B7—liver—obesity	0.000413	0.0145	CbGeAlD
Tapentadol—HTR3A—digestive system—obesity	0.000405	0.0142	CbGeAlD
Tapentadol—CYP2D6—hindbrain—obesity	0.000383	0.0134	CbGeAlD
Tapentadol—SLC6A4—digestive system—obesity	0.000309	0.0108	CbGeAlD
Tapentadol—OPRM1—endocrine gland—obesity	0.000307	0.0107	CbGeAlD
Tapentadol—SLC6A2—adrenal gland—obesity	0.000259	0.00907	CbGeAlD
Tapentadol—CYP2C19—digestive system—obesity	0.000256	0.00896	CbGeAlD
Tapentadol—SLC6A4—endocrine gland—obesity	0.000255	0.00893	CbGeAlD
Tapentadol—CYP2C9—cardiovascular system—obesity	0.000239	0.00837	CbGeAlD
Tapentadol—SLC6A2—endocrine gland—obesity	0.000225	0.00787	CbGeAlD
Tapentadol—CYP2C19—endocrine gland—obesity	0.000211	0.0074	CbGeAlD
Tapentadol—CYP2C9—digestive system—obesity	0.000198	0.00695	CbGeAlD
Tapentadol—CYP2C19—liver—obesity	0.000191	0.00668	CbGeAlD
Tapentadol—CYP2C9—endocrine gland—obesity	0.000164	0.00574	CbGeAlD
Tapentadol—CYP2D6—digestive system—obesity	0.000149	0.00521	CbGeAlD
Tapentadol—CYP2C9—liver—obesity	0.000148	0.00518	CbGeAlD
Tapentadol—Diarrhoea—Diethylpropion—obesity	0.000143	0.00147	CcSEcCtD
Tapentadol—Nausea—Phentermine—obesity	0.000143	0.00147	CcSEcCtD
Tapentadol—Asthenia—Cimetidine—obesity	0.000143	0.00147	CcSEcCtD
Tapentadol—Euphoric mood—Topiramate—obesity	0.000142	0.00146	CcSEcCtD
Tapentadol—Urinary tract infection—Bupropion—obesity	0.000141	0.00145	CcSEcCtD
Tapentadol—Eye disorder—Sibutramine—obesity	0.00014	0.00144	CcSEcCtD
Tapentadol—Immune system disorder—Orlistat—obesity	0.00014	0.00144	CcSEcCtD
Tapentadol—Mediastinal disorder—Orlistat—obesity	0.000139	0.00143	CcSEcCtD
Tapentadol—Dizziness—Diethylpropion—obesity	0.000138	0.00142	CcSEcCtD
Tapentadol—Diarrhoea—Cimetidine—obesity	0.000136	0.0014	CcSEcCtD
Tapentadol—Angiopathy—Sibutramine—obesity	0.000136	0.0014	CcSEcCtD
Tapentadol—Mental disorder—Orlistat—obesity	0.000135	0.00139	CcSEcCtD
Tapentadol—Immune system disorder—Sibutramine—obesity	0.000135	0.00139	CcSEcCtD
Tapentadol—Malnutrition—Orlistat—obesity	0.000134	0.00139	CcSEcCtD
Tapentadol—Disorientation—Topiramate—obesity	0.000134	0.00138	CcSEcCtD
Tapentadol—Chills—Sibutramine—obesity	0.000134	0.00138	CcSEcCtD
Tapentadol—Vomiting—Diethylpropion—obesity	0.000133	0.00137	CcSEcCtD
Tapentadol—Rash—Diethylpropion—obesity	0.000132	0.00136	CcSEcCtD
Tapentadol—Dermatitis—Diethylpropion—obesity	0.000132	0.00136	CcSEcCtD
Tapentadol—Dizziness—Cimetidine—obesity	0.000131	0.00135	CcSEcCtD
Tapentadol—Headache—Diethylpropion—obesity	0.000131	0.00135	CcSEcCtD
Tapentadol—Malnutrition—Sibutramine—obesity	0.00013	0.00134	CcSEcCtD
Tapentadol—Hypoaesthesia—Bupropion—obesity	0.00013	0.00134	CcSEcCtD
Tapentadol—Hallucination—Bupropion—obesity	0.00013	0.00134	CcSEcCtD
Tapentadol—Urinary tract disorder—Bupropion—obesity	0.000129	0.00133	CcSEcCtD
Tapentadol—Hot flush—Topiramate—obesity	0.000128	0.00132	CcSEcCtD
Tapentadol—Connective tissue disorder—Bupropion—obesity	0.000128	0.00132	CcSEcCtD
Tapentadol—Urethral disorder—Bupropion—obesity	0.000128	0.00132	CcSEcCtD
Tapentadol—Tension—Sibutramine—obesity	0.000128	0.00132	CcSEcCtD
Tapentadol—Menopausal symptoms—Topiramate—obesity	0.000127	0.00131	CcSEcCtD
Tapentadol—Vision blurred—Orlistat—obesity	0.000127	0.00131	CcSEcCtD
Tapentadol—Visual disturbance—Topiramate—obesity	0.000127	0.0013	CcSEcCtD
Tapentadol—Nervousness—Sibutramine—obesity	0.000126	0.0013	CcSEcCtD
Tapentadol—Vomiting—Cimetidine—obesity	0.000126	0.0013	CcSEcCtD
Tapentadol—Visual impairment—Bupropion—obesity	0.000126	0.00129	CcSEcCtD
Tapentadol—Rash—Cimetidine—obesity	0.000125	0.00129	CcSEcCtD
Tapentadol—Dermatitis—Cimetidine—obesity	0.000125	0.00129	CcSEcCtD
Tapentadol—Headache—Cimetidine—obesity	0.000125	0.00128	CcSEcCtD
Tapentadol—Nausea—Diethylpropion—obesity	0.000124	0.00128	CcSEcCtD
Tapentadol—CYP2D6—endocrine gland—obesity	0.000123	0.00431	CbGeAlD
Tapentadol—Angioedema—Orlistat—obesity	0.000123	0.00127	CcSEcCtD
Tapentadol—Vision blurred—Sibutramine—obesity	0.000123	0.00126	CcSEcCtD
Tapentadol—Lethargy—Topiramate—obesity	0.000122	0.00126	CcSEcCtD
Tapentadol—Tremor—Sibutramine—obesity	0.000122	0.00126	CcSEcCtD
Tapentadol—Eye disorder—Bupropion—obesity	0.000122	0.00125	CcSEcCtD
Tapentadol—Cardiac disorder—Bupropion—obesity	0.000121	0.00125	CcSEcCtD
Tapentadol—Vertigo—Orlistat—obesity	0.000121	0.00124	CcSEcCtD
Tapentadol—Osteoarthritis—Topiramate—obesity	0.00012	0.00124	CcSEcCtD
Tapentadol—Agitation—Sibutramine—obesity	0.00012	0.00123	CcSEcCtD
Tapentadol—Angioedema—Sibutramine—obesity	0.000119	0.00123	CcSEcCtD
Tapentadol—Palpitations—Orlistat—obesity	0.000119	0.00122	CcSEcCtD
Tapentadol—Angiopathy—Bupropion—obesity	0.000118	0.00122	CcSEcCtD
Tapentadol—Nausea—Cimetidine—obesity	0.000118	0.00122	CcSEcCtD
Tapentadol—Immune system disorder—Bupropion—obesity	0.000118	0.00121	CcSEcCtD
Tapentadol—Mediastinal disorder—Bupropion—obesity	0.000117	0.00121	CcSEcCtD
Tapentadol—Cough—Orlistat—obesity	0.000117	0.00121	CcSEcCtD
Tapentadol—Chills—Bupropion—obesity	0.000117	0.0012	CcSEcCtD
Tapentadol—Vertigo—Sibutramine—obesity	0.000117	0.0012	CcSEcCtD
Tapentadol—Syncope—Sibutramine—obesity	0.000117	0.0012	CcSEcCtD
Tapentadol—Convulsion—Orlistat—obesity	0.000117	0.0012	CcSEcCtD
Tapentadol—Palpitations—Sibutramine—obesity	0.000115	0.00118	CcSEcCtD
Tapentadol—Irritability—Topiramate—obesity	0.000115	0.00118	CcSEcCtD
Tapentadol—Loss of consciousness—Sibutramine—obesity	0.000114	0.00118	CcSEcCtD
Tapentadol—Mental disorder—Bupropion—obesity	0.000114	0.00118	CcSEcCtD
Tapentadol—Anxiety—Orlistat—obesity	0.000114	0.00118	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000114	0.00117	CcSEcCtD
Tapentadol—Cough—Sibutramine—obesity	0.000114	0.00117	CcSEcCtD
Tapentadol—Malnutrition—Bupropion—obesity	0.000113	0.00117	CcSEcCtD
Tapentadol—Ataxia—Topiramate—obesity	0.000113	0.00116	CcSEcCtD
Tapentadol—Convulsion—Sibutramine—obesity	0.000113	0.00116	CcSEcCtD
Tapentadol—Dry mouth—Orlistat—obesity	0.000112	0.00115	CcSEcCtD
Tapentadol—Tension—Bupropion—obesity	0.000111	0.00115	CcSEcCtD
Tapentadol—CYP2D6—liver—obesity	0.000111	0.00388	CbGeAlD
Tapentadol—Arthralgia—Sibutramine—obesity	0.000111	0.00114	CcSEcCtD
Tapentadol—Anxiety—Sibutramine—obesity	0.00011	0.00114	CcSEcCtD
Tapentadol—Nervousness—Bupropion—obesity	0.00011	0.00114	CcSEcCtD
Tapentadol—Anaphylactic shock—Orlistat—obesity	0.00011	0.00113	CcSEcCtD
Tapentadol—Oedema—Orlistat—obesity	0.00011	0.00113	CcSEcCtD
Tapentadol—Infection—Orlistat—obesity	0.000109	0.00112	CcSEcCtD
Tapentadol—Breast disorder—Topiramate—obesity	0.000108	0.00112	CcSEcCtD
Tapentadol—Dry mouth—Sibutramine—obesity	0.000108	0.00112	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Topiramate—obesity	0.000108	0.00111	CcSEcCtD
Tapentadol—Nervous system disorder—Orlistat—obesity	0.000108	0.00111	CcSEcCtD
Tapentadol—Nasopharyngitis—Topiramate—obesity	0.000107	0.00111	CcSEcCtD
Tapentadol—Confusional state—Sibutramine—obesity	0.000107	0.0011	CcSEcCtD
Tapentadol—Vision blurred—Bupropion—obesity	0.000107	0.0011	CcSEcCtD
Tapentadol—Skin disorder—Orlistat—obesity	0.000107	0.0011	CcSEcCtD
Tapentadol—Tremor—Bupropion—obesity	0.000106	0.0011	CcSEcCtD
Tapentadol—Anaphylactic shock—Sibutramine—obesity	0.000106	0.00109	CcSEcCtD
Tapentadol—Oedema—Sibutramine—obesity	0.000106	0.00109	CcSEcCtD
Tapentadol—Hyperhidrosis—Orlistat—obesity	0.000106	0.00109	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Topiramate—obesity	0.000106	0.00109	CcSEcCtD
Tapentadol—Infection—Sibutramine—obesity	0.000106	0.00109	CcSEcCtD
Tapentadol—Shock—Sibutramine—obesity	0.000104	0.00108	CcSEcCtD
Tapentadol—Agitation—Bupropion—obesity	0.000104	0.00107	CcSEcCtD
Tapentadol—Angioedema—Bupropion—obesity	0.000104	0.00107	CcSEcCtD
Tapentadol—Tachycardia—Sibutramine—obesity	0.000104	0.00107	CcSEcCtD
Tapentadol—Skin disorder—Sibutramine—obesity	0.000103	0.00106	CcSEcCtD
Tapentadol—Hyperhidrosis—Sibutramine—obesity	0.000103	0.00106	CcSEcCtD
Tapentadol—Vertigo—Bupropion—obesity	0.000102	0.00105	CcSEcCtD
Tapentadol—Syncope—Bupropion—obesity	0.000102	0.00105	CcSEcCtD
Tapentadol—Palpitations—Bupropion—obesity	0.0001	0.00103	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Orlistat—obesity	0.0001	0.00103	CcSEcCtD
Tapentadol—Loss of consciousness—Bupropion—obesity	9.97e-05	0.00103	CcSEcCtD
Tapentadol—Abdominal discomfort—Topiramate—obesity	9.95e-05	0.00102	CcSEcCtD
Tapentadol—Insomnia—Orlistat—obesity	9.93e-05	0.00102	CcSEcCtD
Tapentadol—Hypotension—Sibutramine—obesity	9.92e-05	0.00102	CcSEcCtD
Tapentadol—Cough—Bupropion—obesity	9.9e-05	0.00102	CcSEcCtD
Tapentadol—Paraesthesia—Orlistat—obesity	9.85e-05	0.00102	CcSEcCtD
Tapentadol—Convulsion—Bupropion—obesity	9.83e-05	0.00101	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Sibutramine—obesity	9.68e-05	0.000997	CcSEcCtD
Tapentadol—Dyspepsia—Orlistat—obesity	9.66e-05	0.000995	CcSEcCtD
Tapentadol—Arthralgia—Bupropion—obesity	9.66e-05	0.000995	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Topiramate—obesity	9.64e-05	0.000993	CcSEcCtD
Tapentadol—Anxiety—Bupropion—obesity	9.63e-05	0.000992	CcSEcCtD
Tapentadol—Insomnia—Sibutramine—obesity	9.61e-05	0.00099	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	9.59e-05	0.000988	CcSEcCtD
Tapentadol—Pollakiuria—Topiramate—obesity	9.58e-05	0.000987	CcSEcCtD
Tapentadol—Erectile dysfunction—Topiramate—obesity	9.55e-05	0.000984	CcSEcCtD
Tapentadol—Decreased appetite—Orlistat—obesity	9.54e-05	0.000983	CcSEcCtD
Tapentadol—Paraesthesia—Sibutramine—obesity	9.54e-05	0.000983	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Orlistat—obesity	9.47e-05	0.000976	CcSEcCtD
Tapentadol—Dyspnoea—Sibutramine—obesity	9.47e-05	0.000976	CcSEcCtD
Tapentadol—Fatigue—Orlistat—obesity	9.46e-05	0.000975	CcSEcCtD
Tapentadol—Dry mouth—Bupropion—obesity	9.45e-05	0.000973	CcSEcCtD
Tapentadol—Somnolence—Sibutramine—obesity	9.44e-05	0.000973	CcSEcCtD
Tapentadol—Weight decreased—Topiramate—obesity	9.39e-05	0.000967	CcSEcCtD
Tapentadol—Dyspepsia—Sibutramine—obesity	9.35e-05	0.000963	CcSEcCtD
Tapentadol—Confusional state—Bupropion—obesity	9.34e-05	0.000962	CcSEcCtD
Tapentadol—Oedema—Bupropion—obesity	9.26e-05	0.000954	CcSEcCtD
Tapentadol—Anaphylactic shock—Bupropion—obesity	9.26e-05	0.000954	CcSEcCtD
Tapentadol—Infestation—Topiramate—obesity	9.25e-05	0.000953	CcSEcCtD
Tapentadol—Infestation NOS—Topiramate—obesity	9.25e-05	0.000953	CcSEcCtD
Tapentadol—Decreased appetite—Sibutramine—obesity	9.23e-05	0.000951	CcSEcCtD
Tapentadol—Depression—Topiramate—obesity	9.22e-05	0.00095	CcSEcCtD
Tapentadol—Infection—Bupropion—obesity	9.2e-05	0.000948	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Sibutramine—obesity	9.17e-05	0.000945	CcSEcCtD
Tapentadol—Shock—Bupropion—obesity	9.11e-05	0.000939	CcSEcCtD
Tapentadol—Constipation—Sibutramine—obesity	9.08e-05	0.000936	CcSEcCtD
Tapentadol—Nervous system disorder—Bupropion—obesity	9.08e-05	0.000936	CcSEcCtD
Tapentadol—Feeling abnormal—Orlistat—obesity	9.04e-05	0.000932	CcSEcCtD
Tapentadol—Tachycardia—Bupropion—obesity	9.04e-05	0.000931	CcSEcCtD
Tapentadol—Skin disorder—Bupropion—obesity	8.99e-05	0.000927	CcSEcCtD
Tapentadol—Urinary tract infection—Topiramate—obesity	8.99e-05	0.000926	CcSEcCtD
Tapentadol—Hyperhidrosis—Bupropion—obesity	8.95e-05	0.000922	CcSEcCtD
Tapentadol—Feeling abnormal—Sibutramine—obesity	8.75e-05	0.000902	CcSEcCtD
Tapentadol—Urticaria—Orlistat—obesity	8.72e-05	0.000898	CcSEcCtD
Tapentadol—Hypotension—Bupropion—obesity	8.65e-05	0.000891	CcSEcCtD
Tapentadol—Bradycardia—Topiramate—obesity	8.45e-05	0.000871	CcSEcCtD
Tapentadol—Urticaria—Sibutramine—obesity	8.44e-05	0.000869	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Bupropion—obesity	8.44e-05	0.000869	CcSEcCtD
Tapentadol—Insomnia—Bupropion—obesity	8.37e-05	0.000863	CcSEcCtD
Tapentadol—Paraesthesia—Bupropion—obesity	8.31e-05	0.000857	CcSEcCtD
Tapentadol—Hallucination—Topiramate—obesity	8.26e-05	0.000851	CcSEcCtD
Tapentadol—Hypoaesthesia—Topiramate—obesity	8.26e-05	0.000851	CcSEcCtD
Tapentadol—Dyspnoea—Bupropion—obesity	8.26e-05	0.00085	CcSEcCtD
Tapentadol—Somnolence—Bupropion—obesity	8.23e-05	0.000848	CcSEcCtD
Tapentadol—Urinary tract disorder—Topiramate—obesity	8.2e-05	0.000845	CcSEcCtD
Tapentadol—Connective tissue disorder—Topiramate—obesity	8.16e-05	0.000841	CcSEcCtD
Tapentadol—Dyspepsia—Bupropion—obesity	8.15e-05	0.00084	CcSEcCtD
Tapentadol—Urethral disorder—Topiramate—obesity	8.14e-05	0.000839	CcSEcCtD
Tapentadol—Hypersensitivity—Orlistat—obesity	8.09e-05	0.000833	CcSEcCtD
Tapentadol—Decreased appetite—Bupropion—obesity	8.05e-05	0.000829	CcSEcCtD
Tapentadol—Visual impairment—Topiramate—obesity	8e-05	0.000824	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Bupropion—obesity	7.99e-05	0.000824	CcSEcCtD
Tapentadol—Fatigue—Bupropion—obesity	7.98e-05	0.000822	CcSEcCtD
Tapentadol—Constipation—Bupropion—obesity	7.92e-05	0.000816	CcSEcCtD
Tapentadol—Asthenia—Orlistat—obesity	7.87e-05	0.000811	CcSEcCtD
Tapentadol—Hypersensitivity—Sibutramine—obesity	7.83e-05	0.000806	CcSEcCtD
Tapentadol—Pruritus—Orlistat—obesity	7.76e-05	0.0008	CcSEcCtD
Tapentadol—Eye disorder—Topiramate—obesity	7.76e-05	0.000799	CcSEcCtD
Tapentadol—Cardiac disorder—Topiramate—obesity	7.71e-05	0.000794	CcSEcCtD
Tapentadol—Feeling abnormal—Bupropion—obesity	7.63e-05	0.000786	CcSEcCtD
Tapentadol—Asthenia—Sibutramine—obesity	7.62e-05	0.000785	CcSEcCtD
Tapentadol—Angiopathy—Topiramate—obesity	7.53e-05	0.000776	CcSEcCtD
Tapentadol—Pruritus—Sibutramine—obesity	7.51e-05	0.000774	CcSEcCtD
Tapentadol—Diarrhoea—Orlistat—obesity	7.51e-05	0.000774	CcSEcCtD
Tapentadol—Immune system disorder—Topiramate—obesity	7.5e-05	0.000773	CcSEcCtD
Tapentadol—Mediastinal disorder—Topiramate—obesity	7.48e-05	0.000771	CcSEcCtD
Tapentadol—Chills—Topiramate—obesity	7.45e-05	0.000768	CcSEcCtD
Tapentadol—Urticaria—Bupropion—obesity	7.36e-05	0.000758	CcSEcCtD
Tapentadol—Mental disorder—Topiramate—obesity	7.27e-05	0.000749	CcSEcCtD
Tapentadol—Diarrhoea—Sibutramine—obesity	7.27e-05	0.000749	CcSEcCtD
Tapentadol—Dizziness—Orlistat—obesity	7.26e-05	0.000748	CcSEcCtD
Tapentadol—Malnutrition—Topiramate—obesity	7.23e-05	0.000745	CcSEcCtD
Tapentadol—Tension—Topiramate—obesity	7.09e-05	0.000731	CcSEcCtD
Tapentadol—Dizziness—Sibutramine—obesity	7.02e-05	0.000724	CcSEcCtD
Tapentadol—Nervousness—Topiramate—obesity	7.02e-05	0.000723	CcSEcCtD
Tapentadol—Vomiting—Orlistat—obesity	6.98e-05	0.000719	CcSEcCtD
Tapentadol—Rash—Orlistat—obesity	6.92e-05	0.000713	CcSEcCtD
Tapentadol—Dermatitis—Orlistat—obesity	6.91e-05	0.000712	CcSEcCtD
Tapentadol—Headache—Orlistat—obesity	6.88e-05	0.000708	CcSEcCtD
Tapentadol—Hypersensitivity—Bupropion—obesity	6.82e-05	0.000703	CcSEcCtD
Tapentadol—Vision blurred—Topiramate—obesity	6.81e-05	0.000702	CcSEcCtD
Tapentadol—Tremor—Topiramate—obesity	6.77e-05	0.000698	CcSEcCtD
Tapentadol—Vomiting—Sibutramine—obesity	6.75e-05	0.000696	CcSEcCtD
Tapentadol—Rash—Sibutramine—obesity	6.7e-05	0.00069	CcSEcCtD
Tapentadol—Dermatitis—Sibutramine—obesity	6.69e-05	0.000689	CcSEcCtD
Tapentadol—Headache—Sibutramine—obesity	6.65e-05	0.000686	CcSEcCtD
Tapentadol—Asthenia—Bupropion—obesity	6.64e-05	0.000684	CcSEcCtD
Tapentadol—Agitation—Topiramate—obesity	6.64e-05	0.000684	CcSEcCtD
Tapentadol—Pruritus—Bupropion—obesity	6.55e-05	0.000675	CcSEcCtD
Tapentadol—Nausea—Orlistat—obesity	6.52e-05	0.000672	CcSEcCtD
Tapentadol—Vertigo—Topiramate—obesity	6.49e-05	0.000669	CcSEcCtD
Tapentadol—Syncope—Topiramate—obesity	6.48e-05	0.000668	CcSEcCtD
Tapentadol—Palpitations—Topiramate—obesity	6.39e-05	0.000658	CcSEcCtD
Tapentadol—Loss of consciousness—Topiramate—obesity	6.35e-05	0.000655	CcSEcCtD
Tapentadol—Diarrhoea—Bupropion—obesity	6.34e-05	0.000653	CcSEcCtD
Tapentadol—Nausea—Sibutramine—obesity	6.31e-05	0.00065	CcSEcCtD
Tapentadol—Cough—Topiramate—obesity	6.31e-05	0.00065	CcSEcCtD
Tapentadol—Convulsion—Topiramate—obesity	6.26e-05	0.000645	CcSEcCtD
Tapentadol—Arthralgia—Topiramate—obesity	6.15e-05	0.000634	CcSEcCtD
Tapentadol—Anxiety—Topiramate—obesity	6.13e-05	0.000632	CcSEcCtD
Tapentadol—Dizziness—Bupropion—obesity	6.12e-05	0.000631	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	6.11e-05	0.00063	CcSEcCtD
Tapentadol—Dry mouth—Topiramate—obesity	6.02e-05	0.00062	CcSEcCtD
Tapentadol—Confusional state—Topiramate—obesity	5.95e-05	0.000613	CcSEcCtD
Tapentadol—Oedema—Topiramate—obesity	5.9e-05	0.000608	CcSEcCtD
Tapentadol—Vomiting—Bupropion—obesity	5.89e-05	0.000607	CcSEcCtD
Tapentadol—Infection—Topiramate—obesity	5.86e-05	0.000604	CcSEcCtD
Tapentadol—Rash—Bupropion—obesity	5.84e-05	0.000601	CcSEcCtD
Tapentadol—Dermatitis—Bupropion—obesity	5.83e-05	0.000601	CcSEcCtD
Tapentadol—Shock—Topiramate—obesity	5.8e-05	0.000598	CcSEcCtD
Tapentadol—Headache—Bupropion—obesity	5.8e-05	0.000598	CcSEcCtD
Tapentadol—Nervous system disorder—Topiramate—obesity	5.79e-05	0.000596	CcSEcCtD
Tapentadol—Tachycardia—Topiramate—obesity	5.76e-05	0.000593	CcSEcCtD
Tapentadol—Skin disorder—Topiramate—obesity	5.73e-05	0.00059	CcSEcCtD
Tapentadol—Hyperhidrosis—Topiramate—obesity	5.7e-05	0.000588	CcSEcCtD
Tapentadol—Hypotension—Topiramate—obesity	5.51e-05	0.000568	CcSEcCtD
Tapentadol—Nausea—Bupropion—obesity	5.5e-05	0.000567	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Topiramate—obesity	5.37e-05	0.000554	CcSEcCtD
Tapentadol—Insomnia—Topiramate—obesity	5.34e-05	0.00055	CcSEcCtD
Tapentadol—Paraesthesia—Topiramate—obesity	5.3e-05	0.000546	CcSEcCtD
Tapentadol—Dyspnoea—Topiramate—obesity	5.26e-05	0.000542	CcSEcCtD
Tapentadol—Somnolence—Topiramate—obesity	5.24e-05	0.00054	CcSEcCtD
Tapentadol—Dyspepsia—Topiramate—obesity	5.19e-05	0.000535	CcSEcCtD
Tapentadol—Decreased appetite—Topiramate—obesity	5.13e-05	0.000528	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Topiramate—obesity	5.09e-05	0.000525	CcSEcCtD
Tapentadol—Fatigue—Topiramate—obesity	5.09e-05	0.000524	CcSEcCtD
Tapentadol—Constipation—Topiramate—obesity	5.04e-05	0.00052	CcSEcCtD
Tapentadol—Feeling abnormal—Topiramate—obesity	4.86e-05	0.000501	CcSEcCtD
Tapentadol—Urticaria—Topiramate—obesity	4.69e-05	0.000483	CcSEcCtD
Tapentadol—Hypersensitivity—Topiramate—obesity	4.35e-05	0.000448	CcSEcCtD
Tapentadol—Asthenia—Topiramate—obesity	4.23e-05	0.000436	CcSEcCtD
Tapentadol—Pruritus—Topiramate—obesity	4.17e-05	0.00043	CcSEcCtD
Tapentadol—Diarrhoea—Topiramate—obesity	4.04e-05	0.000416	CcSEcCtD
Tapentadol—Dizziness—Topiramate—obesity	3.9e-05	0.000402	CcSEcCtD
Tapentadol—Vomiting—Topiramate—obesity	3.75e-05	0.000386	CcSEcCtD
Tapentadol—Rash—Topiramate—obesity	3.72e-05	0.000383	CcSEcCtD
Tapentadol—Dermatitis—Topiramate—obesity	3.72e-05	0.000383	CcSEcCtD
Tapentadol—Headache—Topiramate—obesity	3.7e-05	0.000381	CcSEcCtD
Tapentadol—Nausea—Topiramate—obesity	3.5e-05	0.000361	CcSEcCtD
Tapentadol—UGT1A9—Metabolism—POMC—obesity	2.71e-06	4.08e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—INS—obesity	2.7e-06	4.06e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CB—obesity	2.69e-06	4.04e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NAMPT—obesity	2.68e-06	4.04e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SCARB1—obesity	2.68e-06	4.03e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCK—obesity	2.67e-06	4.01e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LIPC—obesity	2.67e-06	4.01e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—obesity	2.66e-06	4e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NAMPT—obesity	2.66e-06	4e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TYK2—obesity	2.66e-06	4e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOC3—obesity	2.65e-06	3.99e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	2.64e-06	3.98e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LIPC—obesity	2.64e-06	3.98e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCK—obesity	2.64e-06	3.98e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.64e-06	3.97e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS2—obesity	2.64e-06	3.97e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RHOA—obesity	2.64e-06	3.96e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AGT—obesity	2.63e-06	3.96e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOC3—obesity	2.63e-06	3.95e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—obesity	2.62e-06	3.95e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	2.61e-06	3.92e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—obesity	2.61e-06	3.92e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3R1—obesity	2.61e-06	3.92e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—obesity	2.61e-06	3.92e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—INS—obesity	2.61e-06	3.92e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SREBF1—obesity	2.6e-06	3.91e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LEP—obesity	2.58e-06	3.88e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—obesity	2.58e-06	3.88e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CETP—obesity	2.57e-06	3.87e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—obesity	2.57e-06	3.86e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CAV1—obesity	2.56e-06	3.85e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CETP—obesity	2.55e-06	3.84e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOA1—obesity	2.55e-06	3.84e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SDC1—obesity	2.54e-06	3.83e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT2—obesity	2.53e-06	3.81e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—obesity	2.52e-06	3.79e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SDC1—obesity	2.52e-06	3.79e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT2—obesity	2.52e-06	3.79e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CD—obesity	2.5e-06	3.77e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1C3—obesity	2.5e-06	3.76e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.49e-06	3.75e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CA—obesity	2.48e-06	3.74e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1C3—obesity	2.48e-06	3.73e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—FASN—obesity	2.48e-06	3.72e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—obesity	2.47e-06	3.72e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—BCHE—obesity	2.46e-06	3.71e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SCARB1—obesity	2.46e-06	3.71e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ESR1—obesity	2.46e-06	3.71e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SCARB1—obesity	2.44e-06	3.67e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRKCB—obesity	2.43e-06	3.66e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—F2—obesity	2.43e-06	3.66e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CD—obesity	2.42e-06	3.64e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.41e-06	3.62e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CB—obesity	2.41e-06	3.62e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MTOR—obesity	2.41e-06	3.62e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—BAD—obesity	2.4e-06	3.62e-05	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CA—obesity	2.4e-06	3.61e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—obesity	2.4e-06	3.6e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SREBF1—obesity	2.39e-06	3.6e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2E1—obesity	2.38e-06	3.58e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	2.38e-06	3.58e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SREBF1—obesity	2.37e-06	3.57e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3R1—obesity	2.36e-06	3.56e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—obesity	2.36e-06	3.56e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NQO1—obesity	2.35e-06	3.54e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TYK2—obesity	2.33e-06	3.51e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CG—obesity	2.33e-06	3.5e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT2—obesity	2.33e-06	3.5e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RHOA—obesity	2.31e-06	3.48e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT2—obesity	2.31e-06	3.47e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.3e-06	3.46e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS1—obesity	2.3e-06	3.46e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3R1—obesity	2.29e-06	3.44e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—obesity	2.29e-06	3.44e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.28e-06	3.43e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—FASN—obesity	2.28e-06	3.43e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.27e-06	3.42e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—BCHE—obesity	2.27e-06	3.41e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—FASN—obesity	2.26e-06	3.4e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC2A4—obesity	2.25e-06	3.39e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCG—obesity	2.25e-06	3.39e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—BCHE—obesity	2.25e-06	3.38e-05	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT1—obesity	2.23e-06	3.36e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYCS—obesity	2.23e-06	3.35e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—obesity	2.22e-06	3.33e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—INS—obesity	2.2e-06	3.32e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—obesity	2.2e-06	3.31e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2E1—obesity	2.19e-06	3.29e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT1—obesity	2.18e-06	3.28e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT1—obesity	2.18e-06	3.28e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CB—obesity	2.18e-06	3.28e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CA—obesity	2.18e-06	3.28e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2E1—obesity	2.17e-06	3.26e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—obesity	2.17e-06	3.26e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NQO1—obesity	2.16e-06	3.25e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—obesity	2.16e-06	3.25e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NCOA1—obesity	2.15e-06	3.24e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NQO1—obesity	2.14e-06	3.23e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—obesity	2.13e-06	3.21e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT2—obesity	2.13e-06	3.2e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—STK11—obesity	2.12e-06	3.19e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP19A1—obesity	2.12e-06	3.19e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MTOR—obesity	2.11e-06	3.18e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CB—obesity	2.11e-06	3.18e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.1e-06	3.16e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—obesity	2.09e-06	3.15e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.08e-06	3.13e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCG—obesity	2.07e-06	3.12e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC2A4—obesity	2.07e-06	3.12e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCG—obesity	2.06e-06	3.09e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC2A4—obesity	2.06e-06	3.09e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CD—obesity	2.05e-06	3.08e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYCS—obesity	2.05e-06	3.08e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK8—obesity	2.03e-06	3.06e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT1—obesity	2.03e-06	3.05e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYCS—obesity	2.03e-06	3.05e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CA—obesity	2.03e-06	3.05e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—obesity	2.02e-06	3.05e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT1—obesity	2.01e-06	3.02e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT1—obesity	2.01e-06	3.02e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT1—obesity	1.99e-06	3e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT1—obesity	1.99e-06	3e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NCOA1—obesity	1.98e-06	2.98e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—COMT—obesity	1.97e-06	2.96e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TYK2—obesity	1.97e-06	2.96e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NCOA1—obesity	1.96e-06	2.95e-05	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT1—obesity	1.96e-06	2.95e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RHOA—obesity	1.95e-06	2.94e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—STK11—obesity	1.95e-06	2.93e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP19A1—obesity	1.95e-06	2.93e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GNB3—obesity	1.94e-06	2.92e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARGC1A—obesity	1.94e-06	2.92e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMOX1—obesity	1.93e-06	2.91e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—STK11—obesity	1.93e-06	2.91e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP19A1—obesity	1.93e-06	2.91e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—obesity	1.93e-06	2.91e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3R1—obesity	1.93e-06	2.91e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—obesity	1.93e-06	2.9e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GNAS—obesity	1.89e-06	2.85e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—obesity	1.86e-06	2.8e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOB—obesity	1.85e-06	2.79e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CA—obesity	1.84e-06	2.77e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—obesity	1.83e-06	2.76e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—COMT—obesity	1.81e-06	2.73e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—COMT—obesity	1.8e-06	2.7e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARGC1A—obesity	1.79e-06	2.69e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GNB3—obesity	1.79e-06	2.69e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK8—obesity	1.78e-06	2.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CB—obesity	1.78e-06	2.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MTOR—obesity	1.78e-06	2.68e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT1—obesity	1.78e-06	2.68e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMOX1—obesity	1.78e-06	2.68e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GNB3—obesity	1.77e-06	2.67e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARGC1A—obesity	1.77e-06	2.67e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LPL—obesity	1.77e-06	2.66e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMOX1—obesity	1.76e-06	2.65e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GNAS—obesity	1.74e-06	2.62e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MYC—obesity	1.73e-06	2.6e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GPX1—obesity	1.73e-06	2.6e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GNAS—obesity	1.73e-06	2.6e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—obesity	1.72e-06	2.59e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOB—obesity	1.7e-06	2.56e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOB—obesity	1.69e-06	2.54e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CD36—obesity	1.68e-06	2.53e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT1—obesity	1.66e-06	2.49e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CA—obesity	1.64e-06	2.46e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—obesity	1.63e-06	2.45e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—obesity	1.63e-06	2.45e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LPL—obesity	1.63e-06	2.45e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LPL—obesity	1.61e-06	2.43e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—obesity	1.59e-06	2.4e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GPX1—obesity	1.59e-06	2.39e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GPX1—obesity	1.57e-06	2.37e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARA—obesity	1.56e-06	2.35e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—obesity	1.55e-06	2.33e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CD36—obesity	1.55e-06	2.33e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CD36—obesity	1.53e-06	2.31e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MYC—obesity	1.52e-06	2.28e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AGT—obesity	1.51e-06	2.28e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—obesity	1.51e-06	2.27e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK8—obesity	1.51e-06	2.27e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT1—obesity	1.5e-06	2.26e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—obesity	1.48e-06	2.23e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAV1—obesity	1.47e-06	2.21e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CA—obesity	1.47e-06	2.21e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOA1—obesity	1.47e-06	2.21e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—obesity	1.47e-06	2.2e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—obesity	1.45e-06	2.19e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARA—obesity	1.44e-06	2.16e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARA—obesity	1.42e-06	2.14e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.4e-06	2.11e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AGT—obesity	1.39e-06	2.09e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AGT—obesity	1.38e-06	2.08e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—obesity	1.38e-06	2.07e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—obesity	1.36e-06	2.05e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—obesity	1.35e-06	2.03e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAV1—obesity	1.35e-06	2.03e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOA1—obesity	1.35e-06	2.03e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAV1—obesity	1.34e-06	2.02e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CG—obesity	1.34e-06	2.01e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKT1—obesity	1.34e-06	2.01e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOA1—obesity	1.34e-06	2.01e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CA—obesity	1.33e-06	2e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—obesity	1.3e-06	1.95e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—obesity	1.29e-06	1.94e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CA—obesity	1.29e-06	1.94e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MYC—obesity	1.28e-06	1.93e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.28e-06	1.93e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—obesity	1.28e-06	1.92e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—obesity	1.27e-06	1.92e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—INS—obesity	1.27e-06	1.91e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CG—obesity	1.23e-06	1.85e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CG—obesity	1.22e-06	1.84e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT1—obesity	1.2e-06	1.8e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—obesity	1.19e-06	1.79e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—obesity	1.18e-06	1.77e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CD—obesity	1.18e-06	1.77e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—obesity	1.17e-06	1.76e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—INS—obesity	1.17e-06	1.75e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—obesity	1.16e-06	1.75e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—obesity	1.16e-06	1.75e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—INS—obesity	1.16e-06	1.74e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—obesity	1.14e-06	1.71e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3R1—obesity	1.11e-06	1.67e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—obesity	1.11e-06	1.67e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CA—obesity	1.09e-06	1.64e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKT1—obesity	1.09e-06	1.63e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CD—obesity	1.08e-06	1.63e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CD—obesity	1.07e-06	1.61e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—obesity	1.07e-06	1.61e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—obesity	1.06e-06	1.59e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT1—obesity	1.05e-06	1.58e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CB—obesity	1.03e-06	1.54e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—obesity	1.02e-06	1.54e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3R1—obesity	1.02e-06	1.54e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—obesity	1.02e-06	1.53e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—obesity	1.01e-06	1.52e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3R1—obesity	1.01e-06	1.52e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—obesity	9.63e-07	1.45e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CB—obesity	9.43e-07	1.42e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CB—obesity	9.35e-07	1.41e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—obesity	9.35e-07	1.41e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—obesity	9.26e-07	1.39e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT1—obesity	8.88e-07	1.34e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CA—obesity	6.25e-07	9.4e-06	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CA—obesity	5.75e-07	8.65e-06	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CA—obesity	5.7e-07	8.58e-06	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKT1—obesity	5.11e-07	7.68e-06	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKT1—obesity	4.7e-07	7.07e-06	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKT1—obesity	4.66e-07	7.01e-06	CbGpPWpGaD
